News

New dual-action, cancer-killing vaccine tested in an advanced mouse model of glioblastoma

0
Biochemistry laboratory research, Scientist or medical in lab coat holding test tube with Using Microscope reagent with drop of color liquid over glass equipment working at the laboratory.

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, investigators have developed a new cell therapy approach to eliminate established tumors and induce long-term immunity, training the immune system so that it can prevent cancer from recurring.

New findings and recommendations to combat the EVALI epidemic

Previous article

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News